- Preparation of carbamate prodrugs for inhibition of inosine monophosphate dehydrogenase (IMPDH), World Intellectual Property Organization, , ,
Cas no 94994-39-5 (4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid)
94994-39-5 structure
Product Name:4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
CAS No:94994-39-5
MF:C10H19NO4
MW:217.26216340065
MDL:MFCD09831984
CID:1091068
PubChem ID:10656390
Update Time:2024-10-25
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Chemical and Physical Properties
Names and Identifiers
-
- 4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid
- 5-Hydroxymethylisoxazole-3-carboxylic acid ethyl ester
- 4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOIC ACID
- 4-[[(1,1-Dimethylethoxy)carbonyl]methylamino]butanoic acid (ACI)
- 4-[(tert-Butoxycarbonyl)(methyl)amino]butyric acid
- 4-[N-(tert-Butoxycarbonyl)-N-methylamino]butyric acid
- 4-[N-Methyl-N-(tert-butoxycarbonyl)amino]butyric acid
- F8880-8286
- AB6481
- 4-(N-tert-butoxycarbonyl-N-methylamino)butyric acid
- EN300-49664
- 4-((tert-butoxycarbonyl)(methyl)amino)butanoicacid
- 4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoic Acid
- SY107643
- SCHEMBL693386
- PXAKQDWAISFHCM-UHFFFAOYSA-N
- 4-[{[(1,1-Dimethylethyl)oxy]carbonyl}(methyl)amino)butanoic acid
- Z382704896
- Boc-N-methyl-gamma-aminobutyric acid
- 4-{[(tert-butoxy)carbonyl](methyl)amino}butanoic acid
- 94994-39-5
- 4-(N-t-butyloxycarbonyl-N-methylamino)butanoic acid
- CS-W005842
- AS-19947
- 4-(N-BOC-N-METHYL-AMINO)-BUTYRIC ACID
- MFCD09831984
- 4-[(TERT-BUTOXYCARBONYL)(METHYL)AMINO]BUTANOICACID
- 4-((Boc)(methyl)amino)butanoic acid
- 4-(tert-butoxycarbonyl-methyl-amino)-butyric acid
- 4-[{[(1,1-dimethylethyl)oxy]carbonyl}(methyl)amino]butanoic acid
- 4-([(tert-Butoxy)carbonyl](methyl)amino)butanoic acid
- AKOS008126011
- 4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid
-
- MDL: MFCD09831984
- Inchi: 1S/C10H19NO4/c1-10(2,3)15-9(14)11(4)7-5-6-8(12)13/h5-7H2,1-4H3,(H,12,13)
- InChI Key: PXAKQDWAISFHCM-UHFFFAOYSA-N
- SMILES: O=C(N(CCCC(O)=O)C)OC(C)(C)C
Computed Properties
- Exact Mass: 217.13100
- Monoisotopic Mass: 217.13140809g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 15
- Rotatable Bond Count: 7
- Complexity: 232
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1
- Topological Polar Surface Area: 66.8?2
Experimental Properties
- Melting Point: 62-65°C
- PSA: 66.84000
- LogP: 1.71810
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Security Information
- Signal Word:Warning
- Hazard Statement: H315; H319; H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Storage Condition:Store at room temperature
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-FZ296-5g |
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid |
94994-39-5 | 98% | 5g |
3507CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-FZ296-1g |
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid |
94994-39-5 | 98% | 1g |
802.0CNY | 2021-07-13 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-FZ296-250mg |
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid |
94994-39-5 | 98% | 250mg |
416CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-FZ296-100mg |
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid |
94994-39-5 | 98% | 100mg |
265CNY | 2021-05-08 | |
| Chemenu | CM255963-1g |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid |
94994-39-5 | 98% | 1g |
$147 | 2021-06-09 | |
| Chemenu | CM255963-5g |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid |
94994-39-5 | 98% | 5g |
$421 | 2021-06-09 | |
| Chemenu | CM255963-10g |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic acid |
94994-39-5 | 98% | 10g |
$673 | 2021-06-09 | |
| TRC | B810123-50mg |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid |
94994-39-5 | 50mg |
45.00 | 2021-08-15 | ||
| TRC | B810123-100mg |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid |
94994-39-5 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B810123-500mg |
4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid |
94994-39-5 | 500mg |
$ 190.00 | 2023-04-18 |
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Production Method
Production Method 1
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Isopropanol , Acetonitrile ; overnight, rt
Reference
Production Method 2
Reaction Conditions
1.1 Reagents: Potassium carbonate Solvents: 1,4-Dioxane ; 0 °C; 24 h, rt
Reference
- Aminopropyl thiazole derivatives useful as fungicides, and their preparation procedures, Germany, , ,
Production Method 3
Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Dichloromethane , Water ; 48 h, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 5, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 5, rt
Reference
- Peptoads, a group of amphiphilic long-chain triamidesMenger, Fredric M.; Zhang, Hailing, Langmuir, 2005, 21(23), 10428-10438
Production Method 4
Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Tetrahydrofuran
Reference
- Total Synthesis of Cyclosporin on Solid-Phase SupportGerber, Andreas, 2009, , ,
Production Method 5
Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Dimethylformamide ; 0 °C; 6 h, 0 °C
1.2 Reagents: Lithium hydroxide Solvents: Tetrahydrofuran , Water ; overnight, rt
1.3 Reagents: Hydrochloric acid Solvents: Water ; rt
1.2 Reagents: Lithium hydroxide Solvents: Tetrahydrofuran , Water ; overnight, rt
1.3 Reagents: Hydrochloric acid Solvents: Water ; rt
Reference
- Design, synthesis, and cyclization of 4-aminobutyric acid derivatives: potential candidates as self-immolative spacersDeWit, Matthew A.; Gillies, Elizabeth R., Organic & Biomolecular Chemistry, 2011, 9(6), 1846-1854
Production Method 6
Reaction Conditions
1.1 Reagents: Hydrochloric acid Solvents: Water ; 18 h, reflux
1.2 Reagents: Sodium hydroxide Solvents: 1,4-Dioxane , Water ; 10 min, rt; rt → 0 °C
1.3 30 min, 0 °C; 12 h, rt
1.2 Reagents: Sodium hydroxide Solvents: 1,4-Dioxane , Water ; 10 min, rt; rt → 0 °C
1.3 30 min, 0 °C; 12 h, rt
Reference
- Synthesis and evaluation of xanomeline analogs-Probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptorKane, Brian E.; Grant, Marianne K. O.; El-Fakahany, Esam E.; Ferguson, David M., Bioorganic & Medicinal Chemistry, 2008, 16(3), 1376-1392
Production Method 7
Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Water ; 16 h, 100 °C
1.2 Reagents: Sodium bicarbonate Solvents: Tetrahydrofuran , Water ; 14 h, rt
1.2 Reagents: Sodium bicarbonate Solvents: Tetrahydrofuran , Water ; 14 h, rt
Reference
- Preparation of 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as β-lactamase inhibitors, World Intellectual Property Organization, , ,
Production Method 8
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Dichloromethane ; 72 h, rt
Reference
- Preparation of substituted quinolinone derivatives for use as muscarinic receptor antagonists and β2 adrenergic receptor agonists, World Intellectual Property Organization, , ,
Production Method 9
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; 10 min, rt; 1 h, rt
Reference
- Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules, World Intellectual Property Organization, , ,
Production Method 10
Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: 1,4-Dioxane , Water ; 5 min, 0 °C; overnight, rt
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 2 - 3
1.3 Reagents: Sodium hydride Solvents: Tetrahydrofuran ; 2 h, 0 °C
1.4 Solvents: Water ; 0 °C
1.5 Reagents: Hydrochloric acid Solvents: Water ; pH 2 - 3
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 2 - 3
1.3 Reagents: Sodium hydride Solvents: Tetrahydrofuran ; 2 h, 0 °C
1.4 Solvents: Water ; 0 °C
1.5 Reagents: Hydrochloric acid Solvents: Water ; pH 2 - 3
Reference
- Fragment-based domain shuffling approach for the synthesis of pyran-based macrocyclic compoundsComer, Eamon; Liu, Haibo; Joliton, Adrien; Clabaut, Alexandre; Johnson, Christopher; et al, Proceedings of the National Academy of Sciences of the United States of America, 2011, 108(17), 6751-6756
Production Method 11
Reaction Conditions
1.1 Reagents: Sodium hydride Solvents: Tetrahydrofuran ; rt → 0 °C; 16 h, rt
1.2 Reagents: Water ; rt
1.3 Reagents: Hydrochloric acid Solvents: Water ; pH 3, rt
1.2 Reagents: Water ; rt
1.3 Reagents: Hydrochloric acid Solvents: Water ; pH 3, rt
Reference
- Antibody drug conjugates comprising STING modulators, World Intellectual Property Organization, , ,
Production Method 12
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; 10 min, rt; 22 h, rt
Reference
- DC-SiGN antibody conjugates comprising STING receptor agonists and their use in cancer therapy, World Intellectual Property Organization, , ,
Production Method 13
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; 10 min, rt; 22 h, rt
Reference
- Antibody conjugates comprising sting agonist, World Intellectual Property Organization, , ,
Production Method 14
Reaction Conditions
1.1 Reagents: Sodium bicarbonate Solvents: 1,4-Dioxane , Water ; 20 min, 0 °C; 22 h, rt
Reference
- Preparation of chemokine receptor binding (benzimidazol-2-ylmethyl)(5,6,7,8-tetrahydroquinolin-8-yl)amines and related heterocyclic compounds with enhanced efficacy against AIDS and other disorders, United States, , ,
Production Method 15
Reaction Conditions
1.1 Reagents: Sodium hydroxide Solvents: Tetrahydrofuran ; 16 h, rt → 50 °C
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 3 - 4
1.2 Reagents: Hydrochloric acid Solvents: Water ; pH 3 - 4
Reference
- Lipid compound for cell transfection, and liposome and pharmaceutical composition comprising the same for treating genetic abnormality-induced disease, China, , ,
Production Method 16
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; rt; 2 h, rt
Reference
- (R)-N-ethyl-5-fluoro-N-isopropyl-2-((5-(2-(6-((2-methoxyethyl)(methyl)amino)-2-m ethylhexan-3-yl)-2,6-diazaspiro[3.4]octan-6-yl)-1,2,4-triazin-6-yl)oxy)benzamide besylate salt for the treatment of diseases such as cancer, World Intellectual Property Organization, , ,
Production Method 17
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; rt; 2 d, rt
Reference
- Synthesis of Pyridazines or 1,2,4-Triazines containing spirocyclic amines treating cancers and diabetes, World Intellectual Property Organization, , ,
Production Method 18
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Dichloromethane ; rt; 2 h, rt
Reference
- Preparation of substituted spiro derivatives, especially, (R)-N-ethyl-5-fluoro-N-isopropyl-2-[[5-[2-[6-[(2-methoxyethyl)(methyl)amino]-2-methylhexan-3-yl]-2,6-diazaspiro[3.4]octan-6-yl]-1,2,4-triazin-6-yl]oxy]benzami de and its dibesylate as inhibitors of menin-MLL interaction and their use in combination with a BCl-2 inhibitor and optionally one other antitumor agents, World Intellectual Property Organization, , ,
Production Method 19
Reaction Conditions
1.1 Reagents: Triethylamine Solvents: Methanol ; rt; 2 h, rt
Reference
- Combination therapies, World Intellectual Property Organization, , ,
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Raw materials
- Di-tert-butyl dicarbonate
- N-Methyl-4-aminobutyric Acid
- γ-Aminobutyric acid
- 4-(methylamino)butanoic acid;hydrochloride
- Boc-GABA-OH
- N-Methylpyrrolidone
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Preparation Products
4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid Related Literature
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
94994-39-5 (4-{(tert-butoxy)carbonyl(methyl)amino}butanoic acid) Related Products
- 142247-38-9(N-Boc-4-Piperidin-4-yl-butyric Acid)
- 154775-43-6(3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}propanoic acid)
- 952480-32-9(2-(3-tert-butoxycarbonyl-3-azaspiro[5.5]undecan-9-yl)acetic acid)
- 154375-43-6(N-Boc-4-piperidinepropionic acid)
- 1121527-35-2(4-((tert-Butoxycarbonyl)(ethyl)amino)butanoic acid)
- 157688-46-5(2-(1-tert-butoxycarbonyl-4-piperidyl)acetic acid)
- 183062-96-6(2-{1-[(tert-butoxy)carbonyl]azetidin-3-yl}acetic acid)
- 120984-59-0(tert-Butyl 3-Formylpropylmethylcarbamate)
- 100222-98-8(Hexanoic acid, 6-[[(1,1-dimethylethoxy)carbonyl]methylamino]-)
- 1268521-78-3(2-{1-[(tert-butoxy)carbonyl]azepan-4-yl}acetic acid)
Recommended suppliers
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
CN Supplier
Bulk
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
CN Supplier
Bulk
PRIBOLAB PTE.LTD
Gold Member
CN Supplier
Reagent
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
CN Supplier
Bulk
Tiancheng Chemical (Jiangsu) Co., Ltd
Gold Member
CN Supplier
Bulk